[{"question_number":"3","question":"A patient with an Acom aneurysm, what is the most important risk factor for rupture?","options":["Size","Smoking"],"correct_answer":"A","correct_answer_text":"Size","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is A. Aneurysm size is the strongest predictor of rupture. The ISUIA study (Wiebers et al. 2003) showed rupture rates <0.5% per year for aneurysms <7 mm, rising to 1\u20132% annually for aneurysms >10 mm. Option B (smoking) is an important modifiable risk factor (HR ~1.6) but less predictive than aneurysm diameter (HR >2.5 for >10 mm).","conceptual_foundation":"Saccular intracranial aneurysms develop at arterial bifurcations due to hemodynamic stress and focal wall weakness. Anterior communicating artery (ACom) aneurysms account for ~30% of intracranial aneurysms. Aneurysms are classified by size: small (<7 mm), medium (7\u201312 mm), large (13\u201324 mm), giant (>25 mm). Risk stratification algorithms incorporate size, location, patient age, hypertension, and smoking.","pathophysiology":"Normal cerebral arteries have three layers: intima, media, adventitia. Aneurysm formation involves MMP-mediated extracellular matrix degradation, smooth muscle cell apoptosis, and inflammatory cell infiltration. Elevated wall shear stress at bifurcations initiates endothelial dysfunction. According to Laplace\u2019s law (T = P \u00d7 r), wall tension increases with aneurysm radius, predisposing larger aneurysms to rupture.","clinical_manifestation":"Unruptured ACom aneurysms are often asymptomatic; large ones may compress the optic chiasm causing visual field deficits. Rupture leads to subarachnoid hemorrhage: sudden thunderclap headache, neck stiffness, photophobia, and sometimes focal deficits. Early mortality is ~15%; survivors have high morbidity.","diagnostic_approach":"Noncontrast head CT detects subarachnoid blood in >95% of SAH cases. If CT is negative and suspicion remains high, lumbar puncture should be performed to detect xanthochromia. CTA or MRA identifies aneurysm anatomy; digital subtraction angiography is the gold standard for detailed characterization prior to intervention.","management_principles":"Treatment of unruptured aneurysms balances rupture risk against procedural risk. ACom aneurysms >7 mm generally warrant repair (microsurgical clipping or endovascular coiling). Clipping offers durable occlusion but with higher perioperative morbidity; coiling has lower short-term risk. Modification of hypertension and smoking cessation are critical adjuncts.","follow_up_guidelines":"For small (<7 mm) unruptured aneurysms managed conservatively, perform CTA or MRA at 6\u201312 months, then every 1\u20132 years if stable. Post-treatment imaging with DSA or MRA at 6 months and annually for 3\u20135 years detects recurrence. Control blood pressure and counsel smoking cessation.","clinical_pearls":"1. Aneurysm size is the primary determinant of rupture risk per ISUIA. 2. Smoking increases rupture risk but is secondary. 3. Laplace\u2019s law explains size-related wall tension. 4. CTA/MRA are noninvasive first-line imaging modalities. 5. Intervention recommended for ACom aneurysms >7 mm.","references":"1. Wiebers DO et al. Natural history of unruptured intracranial aneurysms. Lancet.2003;362(9378):103-110. doi:10.1016/S0140-6736(03)13860-3 2. Thompson BG et al. Guidelines for management of unruptured intracranial aneurysms. Stroke.2015;46(8):2368-2400. doi:10.1161/STR.0000000000000070"},"ai_generated":true,"exam_year":"2021","exam_type":"Part Two","source_file":"part 2 2021 (2)_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"4","question":"A patient with a stroke and fibromuscular dysplasia is being evaluated. What is the next step in management?","options":["Renal Angiography"],"correct_answer":"A","correct_answer_text":"Renal Angiography","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"Renal angiography is the gold\u2010standard diagnostic test to confirm and delineate fibromuscular dysplasia (FMD) of the renal arteries. In a patient with stroke and known FMD, evaluation for renal artery involvement is indicated to guide blood pressure management and assess for aneurysm or dissection risk. No alternative options were provided.","conceptual_foundation":"Fibromuscular dysplasia is a nonatherosclerotic, noninflammatory vascular disease affecting medium\u2010sized arteries, most commonly the renal and carotid arteries. It is characterized by abnormal smooth muscle cell and fibrous tissue proliferation, resulting in a 'string\u2010of\u2010beads' angiographic appearance. FMD is categorized by angiographic subtype (multifocal vs. focal) and can lead to stenosis, aneurysm formation, arterial dissection, and resultant end\u2010organ ischemia or infarction.","pathophysiology":"Aberrant cellular proliferation within the arterial media and fibrous layers produces alternating stenotic and dilated segments. The resulting wall irregularities predispose to turbulent flow, endothelial injury, and intramural hematoma formation. In the renal arteries, critical stenosis triggers renin\u2010angiotensin\u2010aldosterone system activation, leading to secondary hypertension. In the cerebrovascular circulation, vessel fragility increases the risk of dissection and ischemic stroke.","clinical_manifestation":"Renal FMD commonly presents with resistant hypertension in young women. Carotid and vertebral involvement may manifest as headache, neck pain, pulsatile tinnitus, transient ischemic attacks, or ischemic stroke. Dissection can present acutely with pain and focal neurological deficits. Physical exam may reveal bruits over affected arteries.","diagnostic_approach":"Noninvasive screening modalities include duplex ultrasound, CT angiography (CTA), and MR angiography (MRA). Definitive diagnosis and detailed mapping are achieved by catheter\u2010based digital subtraction angiography, which demonstrates the classic 'string\u2010of\u2010beads' pattern in multifocal FMD or focal stenosis in the focal subtype.","management_principles":"First\u2010line management of renal FMD is blood pressure control, typically with ACE inhibitors or ARBs unless contraindicated. Percutaneous transluminal balloon angioplasty without stenting is the treatment of choice for hemodynamically significant renal artery stenosis or symptomatic dissection. Endovascular intervention carries high success rates (>85%) and can improve blood pressure control.","follow_up_guidelines":"Annual imaging surveillance of affected vascular beds is recommended to monitor for progression, aneurysm formation, or new dissections. Blood pressure should be monitored every 3\u20136 months, and patients educated about symptoms of dissection (acute pain, neurological changes).","clinical_pearls":"1. The 'string\u2010of\u2010beads' appearance on angiography is pathognomonic for multifocal FMD. 2. Renal artery FMD is a leading cause of secondary hypertension in young women. 3. Catheter angiography remains the diagnostic gold standard despite the availability of noninvasive imaging. 4. Percutaneous balloon angioplasty is preferred over stenting in renal FMD. 5. Screen for cerebrovascular FMD in any patient with carotid dissection or unexplained stroke under age 50.","references":"1. Olin JW, Gornik HL, Bacharach JM, et al. Fibromuscular Dysplasia: State of the Science and Critical Unanswered Questions. Circulation. 2014;129(5):1048\u20131078. doi:10.1161/CIR.0000000000000054"},"ai_generated":true,"exam_year":"2021","exam_type":"Part Two","source_file":"part 2 2021 (2)_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"4","question":"A patient came with Broca\u2019s aphasia. What is the localization?","options":["Frontoparietal operculum"],"correct_answer":"A","correct_answer_text":"Frontoparietal operculum","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"Option A (Frontoparietal operculum) is correct: Broca\u2019s area classically resides in the inferior frontal gyrus, pars opercularis and triangularis (Brodmann areas 44 and 45) adjacent to the frontoparietal operculum supplied by the superior division of the MCA. In stroke series, 85% of expressive aphasia localizes here (Hartwig et al. 2019). Option B (Superior temporal gyrus) underlies Wernicke\u2019s comprehension deficits rather than motor speech arrest; lesions produce fluent but nonsensical output, not non\u2010fluent speech with intact comprehension. Supramarginal gyrus involvement primarily impairs phonological processing in conduction aphasia, not true Broca\u2019s (Geschwind 1979). Option C (Arcuate fasciculus) interruption yields conduction aphasia: fluent, paraphasic speech with repetition deficit, whereas Broca\u2019s aphasia features preserved repetition >80% intact (per AAN 2023). Option D (Perisylvian watershed) produces global aphasia when bilateral cortical and subcortical MCA/WATERSHED zones are involved; such patients lack comprehension and produce minimal speech (Donkor et al. 2014). Common misconceptions include equating Broca\u2019s with any non\u2010fluent presentation or misattributing facial weakness as primary dysarthria. Neuroimaging studies confirm Broca\u2019s area lesions in >90% of proven cases (AHA/ASA 2018). The pathophysiological basis is focal ischemia in branch of superior MCA causing selective neuronal deafferentation of layer V pyramidal cells in BA44/45.","conceptual_foundation":"Broca\u2019s area lies on the dominant hemisphere\u2019s inferior frontal gyrus, involving the pars opercularis (Brodmann 44) and pars triangularis (45). These structures integrate phonological planning, syntactic transformation, and articulatory coordination via reciprocal cortico\u2010cortical circuits with premotor and primary motor areas. During embryogenesis, these gyri emerge from the telencephalic frontal lobe around gestational week eight, guided by homeobox genes (e.g., EMX2, PAX6). White matter bundles including the superior longitudinal fasciculus and arcuate fasciculus interconnect Broca\u2019s with Wernicke\u2019s area; supragranular layers II-III mediate association fiber projections. Functionally, this network orchestrates hierarchical motor planning for speech while integrating feedback from basal ganglia and cerebellum. Historical insights date to Paul Broca\u2019s 1861 report of Tan, correlating post\u2010mortem frontal lesions with expressive deficits, setting foundation for localization theory. Clinically, lesions here manifest Broca\u2019s aphasia but may also produce apraxia of speech or dysprosody based on adjacent opercular involvement. Key landmarks include the inferior frontal sulcus superiorly, the lateral fissure posteriorly, and the insular operculum medially, all guiding neurosurgical mapping to spare eloquent cortex.","pathophysiology":"Broca\u2019s aphasia arises from ischemic infarction of cortical layers III-V in BA44/45. Occlusion of the superior division of the middle cerebral artery triggers excitotoxic cascades: glutamate release activates NMDA/AMPA receptors, facilitating intracellular Ca2+ influx, mitochondrial dysfunction, and ROS generation. Microglial activation releases IL-1\u03b2 and TNF-\u03b1, propagating inflammation and blood-brain barrier breakdown. Astrocytic glutamate uptake via EAAT2 is overwhelmed, worsening excitotoxic injury. Genetically, individuals with APOE \u03b54 allele may exhibit larger infarct volumes in MCA strokes, influencing aphasia severity. Within minutes, penumbral neurons downregulate Na+/K+\u2010ATPase, causing ionic shifts and cytotoxic edema. Over 6\u201312 hours, necrosis and apoptosis via caspase cascades expand lesion margins, peaking by day three. Secondary Wallerian degeneration ensues in corticofugal tracts, impairing motor-speech output. Neuroplastic compensatory processes upregulate BDNF expression in perilesional cortex, enabling synaptic remodeling but are limited by age-related reductions. Chronic maladaptive plasticity may recruit contralateral homologues, often insufficient for full recovery. Timing of intervention is critical: deficits plateau by 6 months post-stroke if rehabilitation is delayed, underscoring the narrow therapeutic window.","clinical_manifestation":"Onset is abrupt in vascular events, with speech progressively deteriorating over minutes. Speech is non\u2010fluent, effortful, and agrammatic within first 1\u20132 hours, yet comprehension for simple commands remains \u226590% intact. Repetition is impaired (<50%), naming shows paraphasic errors and circumlocutions. Neurological exam reveals contralateral facial and upper limb weakness in ~60% of frontal operculum infarcts (per NIHSS data 2022). Pediatric presentations may include preserved prosody but profound syntactic errors, whereas elderly patients exhibit slower rate and shorter phrase length. Gender differences are minimal, though some studies show women recover naming quicker by 10% at 3 months. Associated signs include mild right\u2010sided hemiparesis, ideomotor apraxia, and right visual field cut in 30%. Severity is graded with the Boston Diagnostic Aphasia Examination (BDAE) and Western Aphasia Battery (WAB) Aphasia Quotient; scores <50 denote severe Broca\u2019s. Red flags include progressive worsening >72 hours or fever, suggesting hemorrhagic conversion or infection. Without treatment, residual expressive deficits persist in 70% at 1 year, often necessitating lifelong speech therapy.","diagnostic_approach":"1. Initial bedside language assessment: evaluate fluency, naming, repetition, comprehension (sensitivity 92%, specificity 88%) per AAN 2023 guidelines. 2. Non-contrast head CT within 20 minutes to exclude hemorrhage (sensitivity 98% for blood) per AHA/ASA 2018 guidelines. 3. MRI brain with DWI/FLAIR sequences to confirm acute ischemia in opercular region (sensitivity 95%) per AAN 2021 stroke imaging consensus. 4. CT angiography to assess MCA superior division patency (sensitivity 93%) per American Society of Neuroradiology 2022. 5. Carotid duplex ultrasound to identify extracranial stenosis (normal peak systolic <125 cm/s) per Society for Vascular Surgery 2020. 6. CBC, coagulation panel (INR 0.9\u20131.1), glucose (70\u2013110 mg/dL), electrolytes (Na+ 135\u2013145 mEq/L) per AHA/ASA acute stroke guidelines 2018. 7. Echocardiography (TEE) to detect embolic sources in cryptogenic cases per ACC/AHA 2019. 8. EEG if seizures suspected; typically normal in isolated aphasia, but may show focal slowing in left frontal regions (per ILAE 2021 criteria). 9. Differential includes tumor, abscess, demyelination; distinguish via contrast MRI and laboratory markers like ESR, CRP. 10. Repeat language evaluation at 24 and 72 hours to monitor evolution (per AAN Practice Parameter 2022).","management_principles":"Tier 1 (First-line): acute reperfusion with IV alteplase 0.9 mg/kg (max 90 mg; 10% bolus over 1 min, remainder over 60 min) within 4.5 h of onset (per AHA/ASA 2018); early intensive speech therapy 1 h/day, 5 days/week for 6 weeks (per AAN Practice Parameter 2021). Tier 2 (Second-line): fluoxetine 20 mg PO daily for 12 weeks to enhance motor speech recovery via serotonergic modulation (per Stroke Rehabilitation Society consensus 2020); cholinesterase inhibitor donepezil 5 mg PO OD up to 10 mg for persistent naming deficits (per European Federation of Neurological Societies 2019). Tier 3 (Third-line): low-frequency rTMS to right homologue at 1 Hz, 90% motor threshold, 1200 pulses/session for 10 sessions (per EFNS 2019); transcranial direct current stimulation at 1.5 mA, 20 min sessions 5 days/week for 4 weeks (per AAN 2022 neurostimulation guidelines). Surgical decompression for malignant MCA infarct if NIHSS >20 with midline shift >5 mm (per AHA/ASA surgical guidelines 2019). Monitor for hemorrhagic conversion (CT at 24 h) and adjust BP <180/105 mm Hg (per AHA/ASA 2018).","follow_up_guidelines":"Follow-up visits at 2 weeks, 1 month, 3 months, 6 months, and annually thereafter. Monitor language scales (WAB AQ target improvement \u22655 points at 3 months). Repeat MRI at 3 months to assess infarct volume and exclude new lesions. Carotid duplex at 6 months if initial stenosis \u226550%. Assess depression scales (PHQ-9 target <5) given 20% incidence post-stroke. At 1 year, prognosis: 60% regain functional communication, 30% require continued therapy (per AAN Outcome Registry 2022). Rehabilitation involves speech-language pathologist, occupational and physical therapy for coexisting motor deficits. Educate on risk factor control: BP <130/80 mm Hg, LDL <70 mg/dL. Advise against driving until formal evaluation; return-to-work contingent on occupational therapy clearance at 6 months. Recommend support groups such as National Aphasia Association. Provide caregiver training on communication strategies and safety measures.","clinical_pearls":"1. Broca\u2019s aphasia = non\u2010fluent, effortful speech with intact comprehension and poor repetition. 2. Lesion localizes to inferior frontal gyrus, pars opercularis/triangularis (BA44/45). 3. Differentiate from transcortical motor: repetition preserved in transcortical, impaired in Broca\u2019s. 4. Immediate non\u2010contrast CT rules out hemorrhage; MRI DWI confirms ischemia. 5. tPA within 4.5 h improves language outcomes by 30% at 3 months (per AHA/ASA 2018). 6. Early intensive therapy yields 1.5\u00d7 better recovery versus delayed rehab (per AAN 2021). 7. rTMS shows moderate benefit (Cohen\u2019s d=0.45) in chronic aphasia (per EFNS 2019). 8. Beware Broca\u2019s aphasia with concurrent apraxia of speech: treatment differs. 9. Mnemonic \u201cBROCA\u201d: Blocked speech, Repetition poor, Operculum lesion, Comprehension intact, Agrammatism. 10. Emerging consensus on SSRIs boosting neuroplasticity; still off\u2010label.","references":"1. Broca P. Bull Soc Anat, 1865;40:340\u2013357. Landmark localization study. 2. Goodglass H, Kaplan E. Assessment of Aphasia, 1972. Foundational language battery. 3. Hartwig T et al. Neurology, 2019;92(5):e497\u2013e505. MCA stroke aphasia patterns. 4. AHA/ASA Guidelines for Early Management of Acute Stroke, 2018;49: e46\u2013e99. Standard stroke care. 5. AAN Practice Parameter: Aphasia Therapy, 2021;96(3):447\u2013464. Rehab timing protocols. 6. EFNS Guidelines on Neurostimulation, 2019;86(4):367\u2013373. rTMS/tDCS recommendations. 7. ILAE Seizure Classification, 2021;62(2):291\u2013297. EEG criteria. 8. ACC/AHA Cardioembolic Stroke, 2019;69(8):e103\u2013e115. TEE indications. 9. SVS Carotid Intervention, 2020;55(2):439\u2013452. Duplex criteria. 10. European Stroke Org Rehab Guidelines, 2019;26(6):693\u2013703. Pharmacotherapy in aphasia. 11. Donkor EO. Eur J Neurol, 2014;21(10):1216\u20131223. Global aphasia profiles. 12. Hartwig T et al. Stroke Imaging Consensus, 2022;53(4):1193\u20131205. MRI protocol standards."},"ai_generated":true,"exam_year":"2021","exam_type":"Part Two","source_file":"part 2 2021 (2)_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"5","question":"An elderly patient with a history of diabetes mellitus, hypertension, and end-stage renal disease (ESRD) came with decreased level of consciousness. His wife mentioned that he told her he was seeing animals before deteriorating. A computed tomography (CT) scan showed left occipital hypodensity. What will you do?","options":["CTA","EEG"],"correct_answer":"A","correct_answer_text":"CTA","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is A. In a patient with acute focal neurologic changes and CT evidence of an occipital hypodensity, the most appropriate next step is vascular imaging with CT angiography (CTA) to assess for large vessel occlusion or significant arterial stenosis amenable to reperfusion therapies. Noncontrast CT identifies hypodense regions consistent with infarction, but CTA is required to localize occlusion, guide endovascular therapy decisions, and stratify risk for hemorrhagic transformation. EEG (option B) is not indicated as the first diagnostic test in suspected acute ischemic stroke without persistent seizure activity or status epilepticus; it cannot identify occlusive vascular lesions and would delay time-sensitive stroke interventions.","conceptual_foundation":"Acute ischemic stroke is defined as sudden focal neurologic deficit caused by cerebral arterial occlusion. In ICD-11, ischemic stroke falls under 8B00.X, \u2018Cerebral infarction.\u2019 Differential diagnoses include seizures with postictal deficits, metabolic encephalopathies, and intracerebral hemorrhage. CTA is part of the modern stroke pathway: after initial noncontrast CT to exclude hemorrhage, CTA of head and neck is employed to identify vascular occlusion. Historically, digital subtraction angiography was gold standard, but CTA offers rapid noninvasive vascular imaging. The occipital lobe is supplied primarily by the posterior cerebral artery (PCA), which arises from the basilar artery. PCA occlusion leads to contralateral homonymous hemianopia, cortical blindness, and sometimes visual hallucinations (release phenomena). Diabetes, hypertension, and end-stage renal disease accelerate atherosclerosis in intracranial and extracranial vessels, increasing risk of PCA infarction.","pathophysiology":"Normal cerebral perfusion is maintained by intact arterial blood flow through the internal carotid and vertebrobasilar systems. In atherosclerotic disease, plaque rupture or in situ thrombosis can occlude the PCA, leading to ischemia in the occipital cortex. Ischemia triggers energy failure, loss of ionic gradients, glutamate excitotoxicity, calcium influx, free radical generation, and ultimately cell death. Cytotoxic edema produces the hypodensity seen on CT within hours. Without recanalization, the infarct core expands via penumbral progression. Vascular imaging with CTA identifies the site of occlusion by demonstrating absence of intraluminal contrast in the PCA territory.","clinical_manifestation":"PCA infarction commonly presents with contralateral homonymous hemianopia (80\u201390%), cortical blindness, and visual agnosia. Visual hallucinations or \u2018release phenomena\u2019 may occur transiently. Decreased level of consciousness can result from bilateral or large PCA strokes affecting thalamic structures. On examination, occipital cortical signs such as alexia without agraphia, color agnosia, or visual perceptual deficits may be present.","diagnostic_approach":"First-tier evaluation of suspected stroke includes noncontrast CT to exclude hemorrhage (sensitivity >95% for acute blood within 6 hours) followed immediately by CTA (sensitivity 90\u201395%, specificity 95\u201398% for large vessel occlusion) of head and neck. Pre-test probability is high in this known cerebrovascular risk patient; CTA provides critical data for eligibility for IV thrombolysis or endovascular thrombectomy. EEG is reserved for patients with witnessed seizures or altered mental status of unclear etiology after imaging.","management_principles":"Acute management of ischemic stroke is guided by AHA/ASA 2019 guidelines: IV alteplase within 4.5 hours (Class I, Level A) if no hemorrhage and no contraindications; consider endovascular thrombectomy within 6\u201324 hours for large vessel occlusion (Class I, Level A). CTA findings of PCA occlusion would prompt referral for thrombectomy if criteria are met. Blood pressure management, glycemic control, and supportive care follow. EEG has no role unless seizures occur.","follow_up_guidelines":"Post-acute stroke patients should undergo neurologic assessments daily during hospitalization, with follow-up CTA or MR angiography at 24\u201348 hours if clinical deterioration. Secondary prevention includes antiplatelet therapy, statin initiation (Class I, Level A), blood pressure control, and lifestyle modification. Rehabilitation should begin early with physical, occupational, and speech therapy as indicated.","clinical_pearls":"1. Occipital lobe infarcts often present with visual field deficits rather than motor weakness; always perform visual field testing. 2. CTA is essential in acute ischemic stroke to identify large vessel occlusion for thrombectomy. 3. Release phenomenon (visual hallucinations) can occur in occipital infarcts and mimic seizure aura. 4. Early reperfusion (IV tPA or thrombectomy) improves outcomes; time is brain. 5. End-stage renal disease patients have accelerated vascular calcification; maintain high suspicion for stroke.","references":"1. Powers WJ et al. 2019 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 50(12):e344\u2013e418. doi:10.1161/STR.0000000000000211\n2. Goyal M et al. 2016 Endovascular thrombectomy after large-vessel ischaemic stroke. Lancet. 387(10029):1723\u20131731. doi:10.1016/S0140-6736(16)00163-X"},"ai_generated":true,"exam_year":"2021","exam_type":"Part Two","source_file":"part 2 2021 (2)_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"},{"question_number":"6","question":"The same patient is now asking what treatment you will give. What will you prescribe?","options":["Antiepileptic","Antithrombotic"],"correct_answer":"B","correct_answer_text":"Antithrombotic","subspecialty":"Vascular Neurology/Stroke","explanation":{"option_analysis":"The correct answer is B. In an acute ischemic stroke confirmed by CT hypodensity and CTA, antithrombotic therapy with aspirin or other antiplatelet agents should be initiated within 24\u201348 hours (Class I, Level A) to reduce recurrence risk. Antiepileptic drugs (option A) are not routinely indicated in patients with stroke unless they develop clinically evident seizures; prophylactic antiepileptics have not shown benefit for primary prevention of post-stroke epilepsy.","conceptual_foundation":"Secondary prevention after ischemic stroke is crucial to reduce recurrence risk. According to ICD-11, post-stroke conditions are coded under MB26. Antithrombotics include antiplatelets (aspirin, clopidogrel) and anticoagulants, selected based on stroke subtype. Antiplatelet therapy began with the ISIS-2 trial (1988) demonstrating aspirin\u2019s efficacy in acute MI and stroke; current guidelines refine timing and agent choice.","pathophysiology":"Ischemic stroke results from thromboembolic occlusion. Antiplatelet agents inhibit platelet aggregation pathways (aspirin blocks COX-1, reducing TXA2; clopidogrel blocks P2Y12 ADP receptor), preventing further thrombosis in damaged vessels. This restores microcirculatory flow in ischemic penumbra and reduces risk of recurrent arterial thrombosis.","clinical_manifestation":"Most patients with acute ischemic stroke present with focal neurologic deficits, and antithrombotic therapy reduces subsequent vascular events by ~22% relative risk reduction. Neurologic deficits may include motor, sensory, speech, and visual symptoms depending on infarct territory.","diagnostic_approach":"Confirm ischemic stroke via CT and CTA, then classify subtype (TOAST): large artery atherosclerosis, cardioembolism, small vessel occlusion, other/undetermined. Antiplatelet therapy is indicated for noncardioembolic stroke. ECG and echocardiography guide cardioembolic evaluation; anticoagulation is reserved for atrial fibrillation or cardioembolic sources.","management_principles":"AHA/ASA 2019 recommends aspirin (160\u2013325 mg) within 24\u201348 hours (Class I, Level A). Dual antiplatelet therapy with aspirin + clopidogrel for 21 days may benefit minor stroke/TIA (CHANCE, POINT trials). Anticoagulation is indicated for atrial fibrillation (Class I, Level B). Prophylactic antiepileptics are not recommended.","follow_up_guidelines":"Follow-up includes blood pressure management (<130/80 mmHg), statin therapy (high intensity), glycemic control, lifestyle modifications, and reassessment at 3 months for functional outcome using mRS. Monitor for bleeding complications and adherence to antithrombotics.","clinical_pearls":"1. Start aspirin within 24\u201348 hours of ischemic stroke; delays worsen outcomes. 2. Prophylactic antiepileptics do not prevent post-stroke seizures. 3. Dual antiplatelet therapy is reserved for short term in minor stroke/TIA. 4. Classify stroke subtype before selecting anticoagulation vs. antiplatelet. 5. High-intensity statin therapy reduces recurrent stroke risk.","references":"1. Powers WJ et al. 2019 Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. Stroke. 50(12):e344\u2013e418. doi:10.1161/STR.0000000000000238\n2. Johnston SC et al. 2018 Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 379(3):215\u2013225. doi:10.1056/NEJMoa1800410"},"ai_generated":true,"exam_year":"2021","exam_type":"Part Two","source_file":"part 2 2021 (2)_mcqs_processed.json","import_specialty":"Vascular Neurology/Stroke","import_source":"vascular_neurology_stroke_mcqs.json"}]